For patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the ...

New research finds that diet, exercise, and stress management helped improve or stabilize brain function in early-stage ...

Alzheimer’s Pipeline Report, released by the Kirk Kerkorian School of Medicine at UNLV, reveals dozens of promising drug trials that could bring hope to millions of families. The research ...

It wasn’t that long ago when screaming “follow the science” was all the rage, even if the alleged science wasn’t remotely ...

INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has closed its registered direct offering, announced on June 27, 2025, ...

In the Phase 2 MINDFuL trial of XProTM in patients with early Alzheimer's Disease (AD) with biomarkers of inflammation, the modified intent-to-treat ...

I remember the first time I was on stage and scrambled my words. If my lines in a play were supposed to be "Sherwin-Williams, ...

INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early ...

Is it just age-related forgetfulness, or an early sign of something more serious? Neurologists outline the subtle differences ...

This summer, we have launched Dementia Unseen a bold new campaign demanding that the UK Government guarantees the right to an ...

INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early stages of the mind-robbing disease in a mid-stage study, sending its shares ...